Smoking Cessation among Patients with Coronary Heart disease.
- Conditions
- 'coronary heart disease' and 'smoking cessation' 'coronaire hartziekte' en 'stoppen met roken'
- Registration Number
- NL-OMON20676
- Lead Sponsor
- Open Universiteit Nederland, Universiteit Maastricht en Stichting Volksgezondheid en Roken (STIVORO)
- Brief Summary
Berndt, N.C., Bolman, C., Lechner, L., Mudde, A., de Vries, H. (2012). Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description. BMC Cardiovascular Disorders, 12 (1), 33. <br><br> http://www.biomedcentral.com/content/pdf/1471-2261-12-33.pdf
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 894
Patients who are admitted with coronary heart disease at cardiac wards and smoked at least five cigarettes a week prior to hospital admission will be recruted. Inclusion criteria are:
1. Stable cardiac situation;
Exlusion criteria are:
1. Unstable cardiac situation;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome will be point prevalence abstinence from smoking (PPA) after 6 and 12 months. PPA is considered to be the most sensitive and valid measure of smoking cessation.
- Secondary Outcome Measures
Name Time Method